Get to Know BioLegend for Neuroscience

Get to Know BioLegend for Neuroscience

Sponsored Content

With the recent acquisition of the Covance legacy antibodies, BioLegend has expanded its portfolio to enable legendary discoveries in neuroscience research by building a catalog of high quality and innovative tools. Our reagents support research within multiple neuroscience areas, with a great focus on the fields of neurodegeneration, neurodevelopment, neuroinflammation and basic neurobiology.

BioLegend’s neuroscience product categories include: protein misfolding and aggregation, cellular markers, neuroinflammation, synaptic biology, mitochondrial function, and protein trafficking and clearance. BioLegend offers a strong portfolio of reagents that detect native and modified forms of key disease targets in neurodegenerative disorders such as Amyloid-beta, α-synuclein and Tau proteins. We have an extensive collection of well-characterized and highly specific neuroscience cell and structural marker antibodies that allow detection of distinct cell populations in the brain for use in tissue section or cell culture applications.

With over 17,000 products, we offer vast coverage of key immunology products to interrogate inflammatory pathways in the brain. We provide a large portfolio of products to investigate synaptic biology and the underlying mechanisms involved in the pathology of many disorders of the central nervous system. In addition, our portfolio includes a number of products to facilitate research into mechanisms underlying impaired protein trafficking and degradation, as aberrant protein trafficking and clearance contributes to the pathological accumulation of misfolded proteins commonly found in neurodegenerative disorders.

Visit our website to learn more about our product categories and offerings.

You must be logged in to post a comment Login